Skip to main content

Back to Cancer Australia's website

Australian Government - Cancer Australia
Home

Search form

EdCaN - learning resources for nurses

  • EdCaN learning resources
  • Professional development
  • About EdCaN
  • Contact us

Search form

  • Overview
  • Principles of transplantation
  • Sources of stem cells
  • Donor considerations
  • Recipient considerations
  • Bone marrow registries
  • Service delivery
  • The transplant process
  • Acute effects
  • Discharge
  • Chronic effects
  • Late effects
  • References
  1. EdCaN learning resources
  2. Supporting resources
  3. Stem cell transplantation
  4. References
  • Printer-friendly version
  • A|A

References

  • Using the EdCaN resources
  • Case-based learning resources
  • Supporting resources
    • The cancer journey
    • Population health concepts
    • The biology of cancer
    • Cancer treatment planning
    • Surgery
    • Radiotherapy
    • Antineoplastic agents
    • Targeted therapies
    • Stem cell transplantation
      • Overview
      • Principles of transplantation
      • Sources of stem cells
      • Donor considerations
      • Recipient considerations
      • Bone marrow registries
      • Service delivery
      • The transplant process
      • Acute effects
      • Discharge
      • Chronic effects
      • Late effects
      • References
    • Supportive care
    • Aboriginal and Torres Strait Islander peoples
  • Entry to specialty program
  1. Australasian Bone Marrow Transplant Recipient Registry (ABMTRR). ABMTRR Newsletter November 2013. 2013 December 2014.
  2. Australasian Bone Marrow Transplant Recipient Registry (ABMTRR). Annual Data Summary 2012. 2013.
  3. Szer, J., Bone marrow transplantation in 1994. Modern Medicine, 1994: p. 74-83.
  4. National Marrow Donor Program. National Marrow Donor Program home page. 2011 28.10.2011; Available from: https://bethematch.org/.
  5. Devine, H., et al., Mobilization of Hematpoietic Stem Cells for Use in Autologous Transplantation. Clinical Journal of Oncology Nursing, 2010. 14(2): p. 212-222.
  6. Chouinard, M.S. and K.T. Finn, Understanding hematopoiesis, in Blood and marrow stem cell transplantation principles, practice and nursing insights, S.A. Ezzone and K. Schmit-Pokorny, Editors. 2007, Jones and Bartlett Publishers: Sudbury. p. 29-58.
  7. Schmit-Pokorny, K., Blood and marrow transplantation: indications, procedures, process, in Blood and marrow stem cell transplantation principles, practice and nursing insights, S.A. Ezzone and K. Schmit-Pokorny, Editors. 2007, Jones and Bartlett Publishers: Sudbury. p. 75-108.
  8. DeMeyer, E.S., Emerging immunology of stem cell transplantation. Seminars in Oncology Nursing, 2009. 25(2): p. 100-104.
  9. Gyurkocza, B. and M.S. Chouinard, Hematopoietic stem cell transplant immunology, in Blood and marrow stem cell transplantation principles, practice and nursing insights, S.A. Ezzone and K. Schmit-Pokorny, Editors. 2007, Jones and Bartlett Publishers: Sudbury. p. 59-74.
  10. Australian Bone Marrow Donor Registry. Patient Brochure - Stem cell transplantation.  May 2015; Available from: https://www.abmdr.org.au/patient-brochure/
  11. Bray, R.A., et al., National Marrow Donor Program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants. Biology of Blood and Bone Marrow Transplantation, 2008. 14: p. 45-53.
  12. Sacchi, N., et al., Haematopoietic stem cell donor registries: World Marrow Donor Association recommendations for evaluation of donor health. Bone Marrow Transplant, 2008. 42: p. 9-14.
  13. Wingard, J., Bone marrow to blood stem cells past, present, future, in Blood and marrow stem cell transplantation principles, practice and nursing insights, S.A. Ezzone and K. Schmit-Pokorny, Editors. 2007, Jones and Bartlett Publishers: Sudbury. p. 1-28.
  14. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Multiple Myeloma 2012 09.08.2012; Available from: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
  15. World Marrow Donor Association. Education - WMDA Recommendations. 28.10.2011; Available from: https://www.wmda.info/.
  16. Australian Bone Marrow Donor Registry. ABMDR purpose. 2015  Jan 2018; Available from: https://www.abmdr.org.au/abmdr-purpose/
  17. Australian Bone Marrow Transplant Recipient Registry (ABMTRR). Annual Data Summary 2014 08.03.2016; Available from: http://www.abmtrr.org/index.php/annual-data-summary/.
  18. Australian Bone Marrow Donor Registry (ABMDR) and Australian Red Cross Blood Service. How to Join. Jan 2018; Available from: https://www.abmdr.org.au/how-to-join-2/
  19. Neumann, J.L., Ethical issues inherent to blood and marrow transplantation, in Blood and marrow stem cell transplantation principles, practice and nursing insights, S.A. Ezzone and K. Schmit-Pokorny, Editors. 2007, Jones and Bartlett Publishers: Sudbury. p. 369-390.
  20. Sloan, J.M. and K. Ballen, SCT in Jehovah's Witnesses: the bloodless transplant. Bone marrow Transplantation, 2008. 41: p. 837-844.
  21. Tabak, N. and M. Rozen Zvi, When parents refuse a sick teenager the right to give informed consent: the nurse's tole Australian Journal of Advanced Nursing,, 2008. 25(3).
  22. Jacoby, L.H., et al., The basis of informed consent for BMT patients. Bone marrow Transplantation, 1999. 23: p. 711-717.
  23. Franco, T. and R.C. Ford, Models of care delivery for hematopoietic stem cell transplant patients, in Blood and marrow stem cell transplantation principles, practice and nursing insights, S.A. Ezzone and K. Schmit-Pokorny, Editors. 2007, Jones and Bartlett Publishers: Sudbury. p. 423-440.
  24. Joint Accreditation Committee-ISCT & EBMT (JACIE). Joint Accreditation Committee-ISCT & EBMT (JACIE) home page.  May 2015; Available from: http://www.jacie.org/.
  25. American Society for Blood and Marrow Transplantation (ASBMT). American Society for Blood and Marrow Transplantation (ASBMT) home page. 09.08.2012; Available from: http://www.asbmt.org/.
  26. US Department of Health and Human Services, National Institute of Health (NIH), and National Cancer Institute (NCI). Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. 2017 14.03.18; Available from: /sites/default/files/CTCAE_v5_Quick_Reference_5x7%20edcan.pdf (PDF, 2.9MB).
  27. Australian Government, Department of Health and Ageing, and Therapeutic Goods Administration. Therapeutic Goods Administration home page. 2012 09.08.2012; Available from: http://www.tga.gov.au/.
  28. Australian and New Zealand Society of Blood Transfusion (ANZSBT). Australian and New Zealand Society of Blood Transfusion home page. 25.01.2018; Available from: https://www.anzsbt.org.au/​.
  29. Poliquin, C.M., Conditioning regimens in hematopoietic stem cell transplantation, in Blood and marrow stem cell transplantation principles, practice and nursing insights, S.A. Ezzone and K. Schmit-Pokorny, Editors. 2007, Jones and Bartlett Publishers: Sudbury. p. 109-146.
  30. Leger, C.S. and T.J. Nevill, Hematopoietic stem cell transplantation: a primer for the primary care physician. Canadian Medical Association Journal, 2004. 170(10): p. 1569-1577.
  31. Mattsson, J., O. Ringden, and R. Storb, Graft failure after allogeneic hematopoietic cell transplantation. Biology of Blood and Bone Marrow Transplantation, 2008. 14(Supp 1): p. 165-170.
  32. Liesveld, J.L. and P.G. Rothberg, Mixed chimerism in SCT: conflict of peaceful coexistence? Bone marrow Transplantation, 2008. 42: p. 297-310.
  33. Trigg, M.E. and D.m. Inverso, Nausea and vomiting with high-dose chemotherapy and stem cell rescue therapy: a review of antiemetic regimens. Bone marrow Transplantation, 2008. 42: p. 501-506.
  34. Langner, S., et al., Palifermin reduces incidence and severity of oral mucositis in allogenic stem-cell transplant recipients. Bone marrow Transplantation, 2008. 42: p. 275-279.
  35. Ho, V.T., C. Revta, and P.G. Richardson, Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies. Bone marrow Transplantation, 2008. 41: p. 229-237.
  36. Lieow, Y. and M. Christensen, Graft-versus-host diseae in oncology nursing practice. British Journal of Nursing, 2014. 23(10): p. S4, S76, S8-10.
  37. Reddy, P., et al., GVHD: a continuing barrier to the safety of allogenic transplantation. Biology of Blood and Bone Marrow Transplantation, 2008. 15(1): p. 162-168.
  38. Quellmann, S., et al., Corticosteroids for preventing graft-versus-host disease after allogeneic myeloablative stem cell transplantation. Cochrane Database of Systematic Reviews, 2009(3).
  39. Niscola, P., et al., Pain syndromes in the setting of haematopoietic stem cell transplantation for haematological malignancies. Bone marrow Transplantation, 2008. 41: p. 757-764.
  40. National Marrow Donor Program. Recommended post-transplant care. 2007 28.10.2011; Available from: http://marrow.org/Physicians/Post-Transplant_Care/Post-Transplant_Care.aspx.
  41. Rizzo, J.D., et al., Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT//CIBMTR//ASBMT). Bone Marrow Transplant, 2006. 37(3): p. 249-261.
  42. Mosher, C.E., et al., Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature. Psycho-Oncology, 2009. 18(2): p. 113-127.
  43. Anders, V. and M. Barton-Burke, Graft-versus-host disease: complex sequelae of stem cell transplantation, in Blood and Marrow Stem Cell Transplantation Principles, Practice and Nursing Insights, S.A. Ezzone and K. Schmit-Pokorny, Editors. 2007, Jones and Bartlett Publishers: Sudbury. p. 147-182.
  44. National Bone Marrow Transplant Link, et al. Coping with Chronic Graft versus host Disease. 2008 09.08.2012; Available from: http://www.presentme.com/FLASH/20080716NBMTLink/.
  45. Léger, C.S. and T.J. Nevill, Hematopoietic stem cell transplantation: a primer for the primary care physician. Canadian Medical Association Journal, 2004. 170(10): p. 1569-1577.
  46. Horne, B., et al., Psychosocial supportive care services for haematopoietic stem cell transplant patients; a service evaluation of three UK transplant centres. European Journal of Cancer Care, 2014. 23(3): p. 349-362.
  47. Institute of Medicine, Committee on quality health care in America. Crossing the quality chasm: a new health system for the 21st century. 2001, Washington D.C: National Academy Press.
  48. Ruble, K., Late effects of bone marrow transplant, in Blood and Marrow Stem Cell Transplantation Principles, Practice and Nursing Insights, S.A. Ezzone and K. Schmit-Pokorny, Editors. 2007, Jones and Bartlett Publishers: Sudbury. p. 327-338.
  49. Lotfi-Jam, K., P. Schofield, and M. Jefford, What constitutes ideal survivorship care? . Cancer Forum, 2009. 33(3): p. 171-174.
  50. Gates, P. and M. Krishnasamy, Nurse-led survivorship care. Cancer Forum, 2009. 33(3).
  51. National Marrow Donor Program. Patient care post transplant. 2012 09.08.2012; Available from: http://marrow.org/Physicians/Post-Transplant_Care/Post-Transplant_Care.aspx.
  52. Majhail, N., et al., Late effects in survivors of Hodgkin and Non-Hodgkin Lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study. Biology of Blood and Bone Marrow Transplantation, 2007. 13: p. 1153-1159.
  • Copyright © 2021 - Cancer Australia
  • Contact Us
  • Copyright
  • Disclaimer
  • Privacy policy